Cagrilintide: The Amylin Analog That Augments GLP-1 Fat Loss
You think semaglutide is the endgame for weight loss? You haven’t met its partner in crime. Cagrilintide is the long-acting amylin analog that turns a GLP-1 trip into a fat-loss expedition—and the cagrilintide amylin GLP-1 stack is already crushing clinical trials with 17%+ body weight reduction. While the medical establishment drags its feet on FDA […]
Male Enhancement Supplement Science: Beyond Fear-Based Headlines
Legal cases don’t reflect the peer-reviewed research on male enhancement supplements. Here’s what the data actually reveals about risks, benefits, and regulation.
Peptide Debate: Tony Huge’s Take on Medical Controversy
The bodybuilding and biohacking communities are buzzing as mainstream medical organizations intensify scrutiny over peptide therapies. The American Council on Science and Health recently published a critical examination titled “Miracle Molecules or Medical Mirage? the peptide Debate,” raising questions that resonate deeply within Tony Huge’s sphere of influence and research. This developing controversy highlights a […]
Tony Huge on Compounded GLP-1 FDA Changes & Peptide Access
The peptide and biohacking landscape is experiencing significant regulatory shifts that could dramatically impact access to compounds that have become staples in the bodybuilding and longevity communities. Recent developments surrounding compounded GLP-1 medications, along with other peptides like Sermorelin and NAD+, are creating urgent timelines that practitioners in Tony Huge’s sphere need to understand immediately. […]
From Connor McGregor to Brett Favre: The Celebrity Endorsements That Forced Ibogaine Into the Mainstream
Connor McGregor. Brett Favre. Keith Jardine. Jordan Belfort. Three Navy SEALs on Netflix. The HHS Secretary himself. Here is the public testimony stack that broke ibogaine into the mainstream — and why the underground pioneer who made it possible is still in federal prison.
The Pardon Push: Your Complete Toolkit for Freeing Guru Ameen
Copy-paste rep letters, sample tweets, podcast pitch templates, donor pitch language, and a 7-action plan for engaging high-leverage social accounts. The complete pardon toolkit. Pick three. Do them today.
21 Days Later: Guru Ameen Is Still in Federal Prison While the White House Just Legalized His ‘Crime’
Twenty-one days after the executive order legalizing access to ibogaine, my friend Guru Ameen Alai is still in federal prison for distributing it. The cognitive dissonance is unsustainable. Here is the case for a presidential pardon — point by point, with the forensic record laid bare.
FDA GLP-1 Peptide Changes Could Transform Telehealth Access
The peptide landscape is experiencing a significant shift as regulatory changes and market dynamics create new opportunities in the telehealth space. Recent developments surrounding HIMS & HERS Health’s strategic positioning in the glp-1 peptide market have caught the attention of both investors and the biohacking community, with the company’s stock surging 10% in premarket trading […]
J147: The Salk Compound That Might Outperform Donepezil
Curcumin Was a Tease. J147 Is the real Deal. You’ve been sold curcumin as the golden child of anti-aging. Turmeric lattes, black pepper extracts, liposomal this and that. And what did you get? Stomach gurgles, yellow teeth, and a placebo effect you paid thirty bucks a bottle for. The problem isn’t the molecule—it’s that curcumin […]
GLP-1 Muscle Loss: Tony Huge’s Take on Weight Loss Peptides
The growing popularity of glp-1 receptor agonists like semaglutide and tirzepatide has revolutionized the weight loss industry, but new research highlights a critical concern that bodybuilders and fitness enthusiasts cannot ignore: significant muscle loss accompanies the dramatic weight reduction. According to a recent report from AOL.com, while GLP-1 medications deliver impressive weight loss results, users […]